Researchers discover new form of cancer gene regulation
According to the researchers, the “Quaking” gene is likely to suppress tumor growth by inhibiting production of a protein associated with GLI1, a cancer-causing oncogene highly associated with
The US Food and Drug Administration (FDA) has approved PharmaEssentia’s Besremi (ropeginterferon alfa-2b-njft) to treat adults with essential thrombocythaemia (ET).